The stock of Invuity, Inc. (NASDAQ:IVTY) is a huge mover today! About 2.37M shares traded hands or 3705.82% up from the average. Invuity, Inc. (NASDAQ:IVTY) has risen 31.39% since April 4, 2016 and is uptrending. It has outperformed by 30.30% the S&P500.
The move comes after 5 months negative chart setup for the $156.61M company. It was reported on Nov, 4 by Barchart.com. We have $4.51 PT which if reached, will make NASDAQ:IVTY worth $20.36 million less.
Analysts await Invuity, Inc. (NASDAQ:IVTY) to report earnings on November, 8. They expect $-0.70 earnings per share, down 1.45% or $0.01 from last year’s $-0.69 per share. After $-0.76 actual earnings per share reported by Invuity, Inc. for the previous quarter, Wall Street now forecasts -7.89% EPS growth.
Invuity, Inc. (NASDAQ:IVTY) Ratings Coverage
Out of 2 analysts covering Invuity Inc (NASDAQ:IVTY), 2 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Invuity Inc has been the topic of 2 analyst reports since August 29, 2016 according to StockzIntelligence Inc. On Monday, August 29 the stock rating was initiated by Craig Hallum with “Buy”. The firm has “Buy” rating by Lake Street given on Monday, September 19.
According to Zacks Investment Research, “Invuity, Inc. is a medical technology company. Its products include Eikon Illuminated Retractor System, Saber Yankauer, Saber Frazier, Eika Illuminated Retractor System, Breiten Illuminated Retractor System, Eipex Illuminated Retractor System, Eivector Illuminated Retractor System and Waveguide XT System. The Company sells its devices through its direct sales representatives and original equipment manufacturers of surgical systems. Invuity, Inc. is based in San Francisco, California.”
IVTY Company Profile
Invuity, Inc., formerly Spotlight Surgical, Inc., incorporated on May 29, 2015, is a commercial-stage medical technology company. The Firm provides surgeons with direct visualization of surgical cavities during minimally invasive and minimal access surgical procedures. The Firm integrates its Intelligent Photonics technology platform into its single-use and reusable surgical devices to address some of the intracavity illumination and visualization challenges. The Firm utilizes its technology to develop optical waveguides that direct and shape thermally cool, brilliant light into broad, uniform and volumetric illumination of the surgical target. It sells its devices to approximately 530 hospitals.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.